Trump Moves to Fast-Track Psychedelic Drug Research
TL;DR Summary
Trump plans to sign an executive order to accelerate research into psychedelic drugs such as LSD, Ecstasy, and psilocybin and to ease federal restrictions, targeting PTSD, depression and other mental health conditions, with $50 million earmarked for state-level ibogaine studies — a push Texas has already backed with a $50 million commitment.
- Trump Expected to Loosen Restrictions on Psychedelic Drugs The New York Times
- Trump plans to ease access to psychedelics like psilocybin, ibogaine The Washington Post
- Trump to sign executive order on psychedelic drug used abroad to treat PTSD CBS News
- Trump set to ease restrictions on psychedelic drug used to treat PTSD Reuters
- Trump expected to sign executive order urging more research into psychedelic ibogaine CNN
Reading Insights
Total Reads
1
Unique Readers
20
Time Saved
2 min
vs 2 min read
Condensed
86%
384 → 52 words
Want the full story? Read the original article
Read on The New York Times